Search research articles
Contact Us
Filters
Showing results (211-220 of 221) with videos related to
Page
of 23
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
December 26, 2016
Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca<sup>2+</sup> signalling
Serena Stadler, Chi Huu Nguyen, Helga Schachner, et al.
Journal of Medicinal Chemistry
|
February 16, 2021
A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6
Yudao Shen, Fengling Li, Magdalena M Szewczyk, et al.
Nature Cancer
|
July 11, 2022
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nathaniel W Mabe, Min Huang, Guillermo N Dalton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2024
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
Heike Schönherr, Pelin Ayaz, Alexander M Taylor, et al.
Cancer Letters
|
December 3, 2014
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation
Izabella Kiss, Christine Unger, Chi Nguyen Huu, et al.
Nature Communications
|
July 11, 2024
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
Gernot Neumayer, Jessica L Torkelson, Shengdi Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 30, 2015
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation
Christine Unger, Izabella Kiss, Andrea Vasas, et al.
Journal of Medicinal Chemistry
|
October 16, 2004
Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents
Karen L Lobb, Philip A Hipskind, James A Aikins, et al.
Cancer Discovery
|
November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Nature Chemical Biology
|
July 22, 2015
The promise and peril of chemical probes
Cheryl H Arrowsmith, James E Audia, Christopher Austin, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 221) with videos related to
Sort By:
Page
of 23
Cellular and Molecular Life Sciences : CMLS
|
December 26, 2016
Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca<sup>2+</sup> signalling
Serena Stadler, Chi Huu Nguyen, Helga Schachner, et al.
Journal of Medicinal Chemistry
|
February 16, 2021
A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6
Yudao Shen, Fengling Li, Magdalena M Szewczyk, et al.
Nature Cancer
|
July 11, 2022
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nathaniel W Mabe, Min Huang, Guillermo N Dalton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2024
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
Heike Schönherr, Pelin Ayaz, Alexander M Taylor, et al.
Cancer Letters
|
December 3, 2014
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation
Izabella Kiss, Christine Unger, Chi Nguyen Huu, et al.
Nature Communications
|
July 11, 2024
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
Gernot Neumayer, Jessica L Torkelson, Shengdi Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
July 30, 2015
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation
Christine Unger, Izabella Kiss, Andrea Vasas, et al.
Journal of Medicinal Chemistry
|
October 16, 2004
Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents
Karen L Lobb, Philip A Hipskind, James A Aikins, et al.
Cancer Discovery
|
November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Nature Chemical Biology
|
July 22, 2015
The promise and peril of chemical probes
Cheryl H Arrowsmith, James E Audia, Christopher Austin, et al.
Page
of 23